Application Sponsors
ANDA 215472 | STRIDES PHARMA | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | CAPSULE;ORAL | EQ 200MG BASE | 0 | NAPROXEN SODIUM | NAPROXEN SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2022-06-27 | STANDARD |
Submissions Property Types
CDER Filings
STRIDES PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 215472
[companyName] => STRIDES PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"220MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/27\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-06-27
)
)